Form 4: Director William G. Harris Acquires 6,500 Restricted Stock Units in Soleno Therapeutics Inc.

William G. Harris, a director of Soleno Therapeutics Inc., acquired 6,500 restricted stock units on June 6, 2024.

Summary

• On June 6, 2024, William G. Harris, a director of Soleno Therapeutics Inc., acquired 6,500 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of Common Stock.
• The RSUs will vest on the earlier of June 6, 2025, or the day before the next annual stockholder meeting, contingent upon continued service.
• Harris also beneficially owns 15,401 shares of Common Stock, some of which are also RSUs.
• The vested shares from the RSUs will be delivered to Harris upon cessation of services to the Issuer or upon a change of control of the Issuer.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment about the company's prospects.

Future Outlook

The reporting person will receive shares of common stock underlying the RSUs upon cessation of services to the issuer or upon a change of control of the issuer.

Industry Context

This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider activity.

Key Dates